This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ricciardiello, L. Articles by Bazzoli, F. Search for Related Content PubMed PubMed Citation Articles by Ricciardiello, L. Articles by Bazzoli, F.

Frequent Loss of hMLH1 by Promoter Hypermethylation Leads to Microsatellite Instability in Adenomatous Polyps of Patients with a Single First-Degree Member Affected by Colon Cancer¹

Dipartimento di Medicina Interna e Gastroenterologia e Centro di Ricerca Biomedica Applicata [L. R., V. M., S. F., V. L., P. P., R. M. Z., L. D. L., L. F., E. R., F. B.], Istituto di Scienze Statistiche, [T. F.], and Dipartimento Clinico di Scienze Radiologiche e Istocitopatologiche [G. N. M.], Università degli Studi di Bologna, 40138 Bologna, Italy, and Comprehensive Cancer Center and Department of Medicine University of California San Diego, La Jolla, California [L. R., A. G., D. K. C., C. R. B.]

The first-degree relatives of patients affected by colorectal cancer, who do not belong to familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer families, have a doubled risk of developing tumors of the large intestine. We have previously demonstrated that subjects with a single first-degree relative (SFDR) with colon cancer have a doubled risk for developing colorectal adenomas, and in these cases, polyps recur more frequently. The mechanism underlying this predisposition has not been clarified. In this study, we evaluated the frequency of microsatellite instability (MSI) using the five markers suggested by the National Cancer Institute workshop, target gene mutations, hMLH1and hMSH2 expression, and hMLH1promoter hypermethylation in the adenomas of patients with and without a SFDR affected by colon cancer. Seventy polyps were obtained from 70 patients: 27 with a single FDR with colon cancer and 43 without such a history. Of the 70 polyps, 12 were MSI-H (17.1%), 20 were MSI-L (28.6%), and 30 were microsatellite stable (42.9%). Of the 27 patients with positive family history, 8 polyps (29.6%) were MSI-H compared with those with negative history in which 4 polyps (9.3%) were MSI-H (P < 0.02). Of the 12 MSI-H polyps, all of the polyps obtained from patients with positive family history had loss of hMLH1 immunostaining versus one with negative family history (P < 0.02). Of the MSI-H polyps, 2 had a somatic frameshift mutation of the MBD4gene, 1 of MSH6, 1 of BAX, and 2 of transforming growth factor ßRII. Furthermore, 6 of 8 polyps from patients with positive family history with MSI-H and loss of MLH1 had hypermethylation of the MLH1promoter versus none of the MSI-H with negative family history (P < 0.02). All 6 polyps of the 27 from SFDR positive subjects, with hMLH1promoter hypermethylation loss of hMLH1 and MSI, were located in the right colon (P < 0.02). Hypermethylation of the promoter of hMLH1, consequent loss of hMLH1 expression, and MSI are at the basis of 25% of adenomatous polyps developed in subjects with a SFDR affected by colorectal cancer.

This article has been cited by other articles:

				E. I. Joensuu, W. M. Abdel-Rahman, M. Ollikainen, S. Ruosaari, S. Knuutila, and P. Peltomaki Epigenetic Signatures of Familial Cancer Are Characteristic of Tumor Type and Family Category Cancer Res., June 15, 2008; 68(12): 4597 - 4605. [Abstract] [Full Text] [PDF]

				J. A. Chan, J. A. Meyerhardt, D. Niedzwiecki, D. Hollis, L. B. Saltz, R. J. Mayer, J. Thomas, P. Schaefer, R. Whittom, A. Hantel, et al. Association of Family History With Cancer Recurrence and Survival Among Patients With Stage III Colon Cancer JAMA, June 4, 2008; 299(21): 2515 - 2523. [Abstract] [Full Text] [PDF]

				J. Geli, N. Kiss, M. Karimi, J.-J. Lee, M. Backdahl, T. J. Ekstrom, and C. Larsson Global and Regional CpG Methylation in Pheochromocytomas and Abdominal Paragangliomas: Association to Malignant Behavior Clin. Cancer Res., May 1, 2008; 14(9): 2551 - 2559. [Abstract] [Full Text] [PDF]

				J. Yu, M. A. Mallon, W. Zhang, R. R. Freimuth, S. Marsh, M. A. Watson, P. J. Goodfellow, and H. L. McLeod DNA Repair Pathway Profiling and Microsatellite Instability in Colorectal Cancer Clin. Cancer Res., September 1, 2006; 12(17): 5104 - 5111. [Abstract] [Full Text] [PDF]

				L. Ricciardiello, C. Ceccarelli, G. Angiolini, M. Pariali, P. Chieco, P. Paterini, G. Biasco, G. N. Martinelli, E. Roda, and F. Bazzoli High Thymidylate Synthase Expression in Colorectal Cancer with Microsatellite Instability: Implications for Chemotherapeutic Strategies Clin. Cancer Res., June 1, 2005; 11(11): 4234 - 4240. [Abstract] [Full Text] [PDF]

				K. Woodson, D. J. Weisenberger, M. Campan, P. W. Laird, J. Tangrea, L. L. Johnson, A. Schatzkin, and E. Lanza Gene-Specific Methylation and Subsequent Risk of Colorectal Adenomas among Participants of the Polyp Prevention Trial Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1219 - 1223. [Abstract] [Full Text] [PDF]

				R P Coggins, L Cawkwell, S M Bell, G P Crockford, P Quirke, P J Finan, and D T Bishop Association between family history and mismatch repair in colorectal cancer Gut, May 1, 2005; 54(5): 636 - 642. [Abstract] [Full Text] [PDF]

				L.-C. Li, P. R. Carroll, and R. Dahiya Epigenetic Changes in Prostate Cancer: Implication for Diagnosis and Treatment J Natl Cancer Inst, January 19, 2005; 97(2): 103 - 115. [Abstract] [Full Text] [PDF]

				R. L. Ward, R. Williams, M. Law, and N. J. Hawkins The CpG Island Methylator Phenotype Is Not Associated with a Personal or Family History of Cancer Cancer Res., October 15, 2004; 64(20): 7618 - 7621. [Abstract] [Full Text] [PDF]

				J. Gilbert, S. D. Gore, J. G. Herman, and M. A. Carducci The Clinical Application of Targeting Cancer through Histone Acetylation and Hypomethylation Clin. Cancer Res., July 15, 2004; 10(14): 4589 - 4596. [Abstract] [Full Text] [PDF]

				H K Roy and H T Lynch Diagnosing Lynch syndrome: is the answer in the mouth? Gut, December 1, 2003; 52(12): 1665 - 1667. [Full Text] [PDF]

				C. J. Allegra, G. Kim, I. R. Kirsch, B. Iacopetta, H. Elsaleh, N. Zeps, J. J. Jimenez, A. Blanes, S. J. Diaz-Cano, R. Gryfe, et al. Microsatellite Instability in Colon Cancer N. Engl. J. Med., October 30, 2003; 349(18): 1774 - 1776. [Full Text] [PDF]

				M. L. Frazier, L. Xi, J. Zong, N. Viscofsky, A. Rashid, E. F. Wu, P. M. Lynch, C. I. Amos, and J.-P. J. Issa Association of the CpG Island Methylator Phenotype with Family History of Cancer in Patients with Colorectal Cancer Cancer Res., August 15, 2003; 63(16): 4805 - 4808. [Abstract] [Full Text] [PDF]